Source: Fisher BioServices Blog

Fisher BioServices Blog CAR-TCR Summit 2018: Changing lives with CAR-TCR cell therapies

As the past year has proven, the advancements in cell and gene therapy are increasing at a rapid pace and are transforming the way we think about medicine. Whether in research or in the clinic, scientific innovators are acutely aware that every moment counts when working with these valuable therapies. To facilitate knowledge sharing and collaboration, Thermo Fisher Scientific is proud to support the CAR-TCR Summit in Boston.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
1.0-5.0K
CEO Avatar

General Manager

Dennis K. Fallen

CEO Approval Rating

66/100

Read more